Table 2.
IFD | Number of patients (%) | P-value | |
---|---|---|---|
Fluconazole group (n = 65) | Posaconazole group (n = 65) | ||
Patients with proven/probable IFDs | 7 (10.8) | 0 (0) | 0.013 |
Proven/Probable IFDs Pathogen | |||
Mold | 1 (1.5) | ||
Aspergillus | 1 (1.5) | ||
Fusariosis | 1 (1.5) | ||
Zygomycosis | 1 (1.5) | ||
Yeast | 1 (1.5) | ||
Candida albicans | 1 (1.5) | ||
C. glabrata | 1 (1.5) | ||
C.guilliermondii | |||
C. krusei | |||
Patients with possible IFDs | 10 (15.4) | 6 (9.2) | 0.29 |
Total patients with IFDs | 17 (27.0) | 6 (9.2) | 0.012 |
IFD, Invasive fungal disease.